PRECIGEN INC's ticker is PGEN and the CUSIP is 74017N105. A total of 155 filers reported holding PRECIGEN INC in Q1 2020. The put-call ratio across all filers is 0.97 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,380,877 | +27.7% | 972,449 | +3.4% | 0.00% | – |
| Q2 2023 | $1,081,413 | +11.8% | 940,360 | +3.1% | 0.00% | – |
| Q1 2023 | $966,984 | -23.5% | 912,249 | +9.7% | 0.00% | – |
| Q4 2022 | $1,263,699 | -31.9% | 831,381 | -5.0% | 0.00% | – |
| Q3 2022 | $1,856,000 | +53.6% | 875,052 | -3.0% | 0.00% | – |
| Q2 2022 | $1,208,000 | -49.9% | 902,158 | -21.0% | 0.00% | – |
| Q1 2022 | $2,411,000 | -32.8% | 1,142,683 | +18.2% | 0.00% | – |
| Q4 2021 | $3,586,000 | -22.3% | 966,365 | +4.5% | 0.00% | -100.0% |
| Q3 2021 | $4,615,000 | -42.1% | 924,968 | -24.4% | 0.00% | 0.0% |
| Q2 2021 | $7,973,000 | +30.8% | 1,222,855 | +38.2% | 0.00% | 0.0% |
| Q1 2021 | $6,096,000 | -17.5% | 884,800 | +22.1% | 0.00% | 0.0% |
| Q4 2020 | $7,392,000 | +94.4% | 724,679 | -33.3% | 0.00% | 0.0% |
| Q3 2020 | $3,803,000 | +11.7% | 1,086,594 | +59.2% | 0.00% | 0.0% |
| Q2 2020 | $3,406,000 | +51.7% | 682,634 | +3.3% | 0.00% | 0.0% |
| Q1 2020 | $2,245,000 | – | 660,564 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Patient Capital Management, LLC | 13,753,176 | $19,529,510 | 1.15% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 2,078,220 | $2,951,072 | 0.60% |
| EMFO, LLC | 425,000 | $603,500 | 0.57% |
| Opaleye Management Inc. | 928,500 | $1,318,470 | 0.43% |
| First Washington CORP | 646,575 | $918,137 | 0.37% |
| Fore Capital, LLC | 426,791 | $606,043 | 0.26% |
| SANDERS MORRIS HARRIS LLC | 410,000 | $582,200 | 0.12% |
| MSD Partners, L.P. | 960,000 | $1,363,200 | 0.11% |
| Virtus ETF Advisers LLC | 79,754 | $113,251 | 0.07% |
| CHIRON CAPITAL MANAGEMENT, LLC | 55,850 | $79,307 | 0.07% |